Pathology of gliomas and developments in molecular testing

Area of Science:

• Neuro-oncology
• Molecular pathology
• Cancer genomics

Background:

• Human brain tumors are increasingly characterized using advanced technologies.
• Histopathology of common gliomas is being integrated with molecular data.
• Molecular subtypes are emerging within single histological entities.

Purpose of the Study:

• To summarize the histopathology of common gliomas.
• To integrate molecular data with glioma histopathology.
• To discuss the clinical relevance of molecular data in brain tumor diagnosis and treatment.

Main Methods:

• Review of current literature on glioma histopathology and molecular profiling.
• Integration of histological classifications with molecular subtypes.
• Analysis of clinical relevance of molecular data for conventional therapies.

Main Results:

• Some histological entities comprise multiple molecular subtypes.
• Different histological entities can share molecular similarities.
• Molecular data shows clinical relevance for conventional therapies in certain cases.

Conclusions:

• Molecular characterization is revolutionizing brain tumor classification.
• The emergence of targeted therapies requires a reevaluation of pathology reporting.
• Pathology reports must adapt to reflect molecular findings for improved patient care.